Mirvetuximab-MMAE
Product Specifications
Additionnal Information
Mirvetuximab-MMAE is an ADC targeting FOLR1 (folate receptor 1) . It can be used in ovarian and other FRα-positive cancer research. MW :145.96 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog